Discover the emerging field of AI-based peptide discovery and design – could this signal the beginning of a golden age for ...

Discover five promising Prader-Willi syndrome therapies climbing the clinical ladder and nearing FDA approval in the coming ...

Home to a well-established hub with strong investment and startup activity, discover what makes Cambridge's biotech scene so ...

BIOSPAIN showed how partnering conferences connect public funding, venture capital, and pharma to drive biotech innovation to ...

The Asabys-Aliath integration signals how European biotech VCs are scaling and adapting amid funding pressures.

Discover the top biotech deals of September 2025, as four billion-dollar acquisitions took place and several licensing deals ...

Discover how AKIGAI’s EGFR inhibitors may redefine neuropathic pain therapy and offer hope for complex regional pain syndrome ...

How does the addition of GLP-1 drugs to the WHO essential medicines list affect prices? While GLP-1 agonists were already on the map before, as they became popular for their effectiveness in treating ...

Once a booming field, bustling with innovation and money driving that innovation, the cell and gene therapy sector is now struggling to fuel therapeutic growth to bring medicines to patients. It doesn ...

Nature writes the best horror stories – In The New York Times’ recent piece, the return of the screwworm, a flesh‑eating parasite once eradicated from the U.S. Indeed, cattle ranchers are once again ...